ERBB2 oncogenic variants
About
Gene context: ERBB2
Biomarker Type: Somatic Variant
Present: True
Chromosome: 17
Requires Oncogenic: True
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | ERBB2 oncogenic variants | Non-Small Cell Lung Cancer | Trastuzumab deruxtecan | |
| Sensitivity (+) | ERBB2 oncogenic variants | Non-Small Cell Lung Cancer | Trastuzumab deruxtecan |